Health Canada
Symbol of the Government of Canada

Common menu bar links

About Health Canada

Access to Information Requests Completed - August 2015

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of August 2015
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2012-01343 All records related to proposals around a joint federal/provincial bulk drug purchasing plan (Jan. 1, 2012 to Jan. 14, 2013) Disclosed in part 198
A-2013-00438 Information regarding Humira (adalimumab), Drug Identification Number (DIN) 02258595 by Abbott Laboratories Limited or Abbvie Corporation. Disclosed in part 29
A-2014-00627 Documents regarding bidis and kreteks reported or filled by every tobacco manufacturer and importer under Section 13 of the Tobacco Reporting Regulations during the following period: Jan. 1, 2013 to Aug. 21, 2014; Jan. 1, 2009 to Dec. 31, 2012.  This excludes Imperial Tobacco Canada, JTI-MacDonald and Rothmans Benson & Hedges. Disclosed in part 63
A-2014-00888 Adverse Reaction Report (AER) for Eligard (leuprorelin acetate). Report number: E2B_00035517. All disclosed 6
A-2014-00891 Adverse Reaction Report (AER) for Eligard (leuprorelin acetate). Report number: ID:000543694. Disclosed in part 12
A-2014-00979 Adverse Reaction Report (AER) for GARDASIL. Report numbers: 000468794, 000468797, 000469545, 000484024, 000495593, 000496041, 000496047, 000496867, 000502044, 000504081, 000504294, 000505523, 000509301, 000530041, 000536971, 000544560, 000545215, 000560040, 000561070, 000562563. Disclosed in part 79
A-2014-00980 Adverse Reaction Report (AER) for GARDASIL. Report numbers: 000564666, 000567800, 000570695, 000570706, 000570848, 000580248, 000592394, 000603555, E2B_00043111, E2B_00045073, E2B_00045488, E2B_00080958, E2B_00085730, E2B_00085731, E2B_00085732, E2B_00085733, E2B_00085734, E2B_00085735, E2B_00085736, E2B_00085737, E2B_00085738, E2B_00085739, E2B_00085740, E2B_00085744, E2B_00094519, and E2B_00104998. Disclosed in part 171
A-2014-01298 Adverse Reaction Report (AER) for HUMIRA. Report numbers: 000615899,000615909, 000616497 and 000616865. Disclosed in part 29
A-2014-01309 Copy of documents prepared for Dr. Marc Berthiaume and Dr. Supriya for their appearance as witnesses before the Standing Senate Committee on Social Affairs, Science and Technology on April 17, 2013. All disclosed 70
A-2014-01325 A list of all briefing notes to the minister for January 2015, including the title, subject matter, date, author and reference number Disclosed in part 10
A-2014-01345 A list of briefing materials created for the Minister and Deputy Minister during the month of January 2015 Disclosed in part 10
A-2014-01461 Copies of any application for renewal and supporting documents filed by Tweed to produce medical marihuana in Canada under the Marihuana for Medical Purposes Regulations (MMPR) Disclosed in part 47
A-2014-01475 Communication created and discussed over the licensing of DUKORAL from the time of receipt of the Priority Evaluation Request on July 12, 2001 to the first received Clarifax on October 30, 2001. Disclosed in part 28
A-2015-00083 Adverse Reaction Report (AER) for HUMIRA. Report numbers: 000635617, E2B_00191415, 000635658 and E2B_00194012. Disclosed in part 33
A-2015-00085 Adverse Reaction Report (AER) for HUMIRA. Report numbers: E2B_00157312, 000633447 and E2B_00185194. Disclosed in part 53
A-2015-00091 Adverse Reaction Report (AER) for HUMIRA. Report numbers: 000636495, 000636774  and E2B_00208807. Disclosed in part 27
A-2015-00096 All documents in Ministerial Executive Correspondence System (MECS) for the file number 12-114512-849 All exempted 0
A-2015-00126 Copy of letter(s) from this institution to Novopharm Limited certifying that the examination of Novopharm’s Dorzolamide / Timolol solution was completed, that the product was approved and that a Notice of Compliance would not be issued until the requirements of the Patented Medicines Regulations were met. Disclosed in part 2
A-2015-00157 Adverse Reaction Report (AER) for Epipen. Report numbers: 000133039, 000226317, 000303474, 000309082, 000311802, 000313195, 000313723, 000317678, 000327819, 000327856, 000346444, 000377110, 000403504, 000553251, 000573362, 000588647, 000602545, 000612250, 000620957, 000622138, 000636913 and 000636914. Disclosed in part 83
A-2015-00194 Adverse Reaction Report (AER) for GARDASIL. Report numbers: 000621473, E2B_00185326, E2B_00187953, E2B_00187967, E2B_00187969, E2B_00187972, E2B_00187973, E2B_00187976, E2B_00195812 and E2B_00197862). Disclosed in part 63
A-2015-00201 Documentation based on the Pest Management Regulatory Agency findings on the chemical Glyphosate, an active ingredient in Monsanto’s RoundUp herbicide, including the safety assessment showing that Glyphosate is safe for being present in Canadian food, in Canadian people, animals, and in Canadian environment. All disclosed 330
A-2015-00209 All written correspondence written by Health Canada to either Resolve Research Solutions, or Celina Chavez in her capacity as CEO of that company, concerning any and all instances in which the company undertook paid work for Health Canada, was the subject of an audit by Health Canada, or was found by Health Canada to not be in regulatory compliance.  No records exist 0
A-2015-00217 Documents related to the meeting of August 18, 2014 between the Minister Ambrose, the Deputy Minister, the Chief Public Health Officer, officials from Agriculture and AgriFood Canada (including the Minister) and representatives of the Canadian Supply Chain Food Safety Coalition. No records exist 0
A-2015-00232 Information related to access to information requests received between January 1, 2012 and June 15, 2015. Disclosed in part 1,416
A-2015-00252 Documentation concerning the Résidence La Rosière in Sainte-Julie, Quebec, that is, whether this corporation, operated by the Société immobilière SYM Inc., is in compliance with Health Canada: amounts due, infraction notices and whether it was inspected or was the subject of complaints. No records exist 0
A-2015-00257 Copies of the following briefing note provided to the Minister: 15-100025-728, CMA's proposal for funding surrounding the Taming of the Queue 2015 Disclosed in part 9
A-2015-00267 Documentation relating to a complaint made to this institution in regards to the allegation concerning web site publicity and labelling for the product Bambousil in July and August 2014. All disclosed 2
A-2015-00274 Documentation which indicates all appointments term and casual employees by Public Health Agency of Canada in the National Capital Region under the term of the Public Service Employment Act during the period of April to May 2015.. All disclosed 1
A-2015-00276 Documents indicating the number of Health Canada nurses who worked for the Department as employees or on contract for the years 2005 to 2015 (June 23, 2015) All disclosed 1
A-2015-00278 Documents indicating the number of Health Canada nurses who worked for the Department in Aboriginal communities as employees or on contract for the years 2005 to 2015 (June 23, 2015) All disclosed 1
A-2015-00280 Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during April and May 2015. All disclosed 3
A-2015-00297 Copies of the following briefing note provided to the Minister: 15-102441-658 - Call on E-Cigarettes Communications Plan Disclosed in part 3
A-2015-00305 Copies of the following briefing note provided to the Minister: 15-001450-836 - Invitation to symposium on "Cognition is the Ignition of a Brain-Driver Economy", March 25, 2015 Disclosed in part 3
A-2015-00310 Documentation which indicates all appointments term and casual employees by Public Health Agency of Canada in the National Capital Region under the term of the Public Service Employment Act during June 2015. All disclosed 1
A-2015-00311 Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during June 2015. All disclosed 2
A-2015-00312 All call-ups/Contracts processed by this institution in the National Capital Region under the terms of Standing Offer or Supply Arrangement for Temporary Help Services during the period of June 2015. Disclosed in part 52
A-2015-00319 List of every contract awarded by Health Canada for studies and research by businesses, individuals or universities demonstrating the type of study/research requested, the name of the supplier or author and monetary value (Feb. 1, 2015 to July 7, 2015) All disclosed 13
A-2015-00320 Documents related to the underage minor’s attempt to buy tobacco at 7-Eleven Stores contained within this institution final report on Evaluation of Retailors Behaviour Towards Certain Youth Access-to-Tobacco Restrictions: March 2015 report. No records exist 0
A-2015-00321 Communication regarding the treatment of inmates with hepatitis C, using the drugs Sovaldi and Harvoni (June 18 to June 30, 2015) No records exist 0
A-2015-00323 Documents related to the 2015 Noise Conference held in Glasgow, Scotland including correspondence, expenditures, trip itineraries, attendees and meeting/preparation papers. Disclosed in part 97
A-2015-00324 Documents related to the 2015 Noise Conference held in Pittsburgh, United States including correspondence, expenditures, trip itineraries, attendees and meeting/preparation papers. Disclosed in part 59
A-2015-00338 Documents and correspondence regarding the publication Blacklock’s Reporter including any use and distribution of content via the account purchased July 14, 2015. All disclosed 8
A-2015-00339 The Table of Contents (TOC) from Leo Pharma’s INNOHEP (tinzaparin sodium) Supplement to a New Drug Submission (SNDS), Control No. 176005, approved May 27, 2015 No records exist 0
A-2015-00340 All call-ups/Contracts processed by this institution in the Western Region, specifically the city of Calgary and the Pacific Region, specifically for Vancouver, Burnaby, Delta, Langley, Richmond, Abbotsford and Surrey under the terms of Standing Offer or Supply Arrangement for Temporary Help Services during the period of December 2014, January, February and March 2015.. All disclosed 1
A-2015-00347 Documents related to individuals and businesses  applying to the Marihuana for Medical Purposes Regulation program and seeking a license to establish their business/production facility in the City of Maple Ridge, British Columbia All excluded 0
A-2015-00352 Documents regarding the meeting between the Environmental and Radiation Health Sciences Directorate (ERHSD) of the Healthy Environments and Consumer Safety Branch (HECSB), and the consultation (July 15, 2014 to July 15, 2015) No records exist 0
A-2015-00354 Communications between Dr. James McNamee of ERHSD-HECSB, the Director or Director General of Strategic Planning, Andrew Adams or replacement, Dr. Art Thansandote and the Minister Rona Ambrose with respect to the letter of July 16, 2014 sent by Frank Clegg of Canadians for Safe Technology (Sept. 5, 2014 to July 16, 2015) No records exist 0
A-2015-00358 Any correspondence provided or submitted by E.I. du Pont Canada Company or any DuPont entity authorizing Cheminova to use DuPont’s data in support of its registration for Thifensulfuron and Tribenuron technical active ingredients under the Pest Control Products Act and Regulations (2008-2009) No records exist 0
A-2015-00365 Copy of all documents held by Health Canada indicating the number of overtime hours worked and the total monetary value of overtime paid to Health Canada employees from 2005 to date (July 20, 2015). All disclosed 2
A-2015-00369 Adverse Reaction Report (AER) for Plavix (clopidogrel bisulfate). Report number: ID: 000628706 Disclosed in part 1
A-2015-00370 Adverse Reaction Report (AER) for Tubersol Vaccine. Report number: 000639505. Disclosed in part 1
A-2015-00372 Adverse Reaction Report (AER) for report numbers: 000638099, 000638106 and 000642876. Disclosed in part 7
A-2015-00377 Documentation regarding to the use of McIntyre Powder Aluminum Dust as a prophylaxis treatment in mining and other silica dust-producing industries, especially result of the McIntyre Research Foundation’s request for approval under the Food & Drugs Division in July 1947. No records exist 0
A-2015-00389 Adverse Reaction Report (AER) for Fluzone vaccine. Report number: 000644544. Disclosed in part 2
A-2015-00390 Adverse Reaction Report (AER) for Adacel vaccine. Report number: 000647804. Disclosed in part 1
A-2015-00391 Adverse Reaction Report (AER) for Adacel vaccine. Report number: 000646085. Disclosed in part 1
A-2015-00393 Copy of the official statement made at the Denver Noise Conference 2013 stating that the 2009 Night Noise Guidelines for Europe can be applied to industrial wind turbines. All exempted 0
A-2015-00394 Documents (dashboard) related to the Application Processing the Licensing Activities under the Marihuana for Medical Purposes Regulations for April 30, 2015, May 2015 and June 30, 2015. All disclosed 6
A-2015-00425 Adverse Reaction Report (AER) for K-Dur. Report number: 000395293. Disclosed in part 2
A-2015-00426 Adverse Reaction Report (AER) for Marvelon. Report numbers: 000454930, 000465180, 000485158, 000499018 and 000511530. Disclosed in part 8
A-2015-00432 Adverse Reaction Report (AER) for Eloxatin (oxaliplatin). Report number: 00632011. Disclosed in part 1
A-2015-00512 Documents produce by Health Canada in connection with Nestlé Water facilities (Jan. 1, 2012 – Aug. 7, 2015) No records exist 0
A-2015-00531 Adverse Reaction Report (AER) for Venofer. Report numbers: 000646222, 000646920 and 000647026. Disclosed in part 5